Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 16 November 2015
Author/s

author: Marc S Raab  Philippe Moreau  Sagar Lonial  Andrzej Jakubowiak  Sagar Lonial  Lotfi Benboubker  Eric Bleickardt  Thierry Facon  Paul G. Richardson  Sundar Jagannath  Kenneth C. Anderson  Jeffrey A Zonder  Donna E Reece  Ravi Vij 

Publication date November 16, 2015
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item